Join
Live feed
·
PRReleasevia Quantisnow
Gilead Sciences Inc. logo

EQT Life Sciences to exit minority stake in Tubulis via sale to Gilead Sciences for up to USD 5.0 billion

ByQuantisnow·Wall Street's wire, on your screen.
GILD· Gilead Sciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GILD (Gilead Sciences Inc.) and more on Quantisnow.